查找临床试验

已按「年龄相关性黄斑变性」检索,对应国际通用词 age-related macular degeneration

试验不在中国怎么办?

共找到 12 项正在招募的试验(在欧美日韩等发达国家设有中心)

数据更新于 11:24,每 5 分钟自动同步
正在招募不适用NCT05454124

Factors in Learning And Plasticity: Macular Degeneration

United States

年龄 18 Years89 Years

University of Alabama at Birmingham

正在招募III 期NCT07064759

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

United States、Argentina、Australia、Bulgaria、Germany 等 12 国

年龄 50 Years不限

4D Molecular Therapeutics

正在招募II 期NCT05626114

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

United States、Israel

年龄 50 Years不限

Genentech, Inc.

正在招募II 期中国有中心NCT06962839

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

United States、China、Czechia、Germany、Hungary 等 9 国

年龄 18 Years不限

Boehringer Ingelheim

正在招募不适用NCT07577219

Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss

United States

年龄 14 Years不限

New England College of Optometry

正在招募不适用NCT06906003

Visual Rehabilitation and Depression in Visually Impaired Patients With AMD

Italy

年龄 55 Years不限

Fondazione G.B. Bietti, IRCCS

正在招募II 期NCT06659445

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

United States、Austria、Canada、Czechia、Germany 等 12 国

年龄 55 Years不限

ONL Therapeutics

正在招募不适用中国有中心NCT06346600

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

United States、China

年龄 50 Years不限

Skyline Therapeutics

正在招募III 期NCT06847542

A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD

Austria、Czechia、Denmark、France、Germany 等 12 国

年龄 50 Years不限

Hoffmann-La Roche

正在招募不适用NCT02026843

Analysis of Biomarkers From Patients With Chorioretinal Diseases

South Korea

年龄 20 Years80 Years

Kyungpook National University Hospital

正在招募III 期NCT07614776

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

United States、Latvia、Poland、Slovakia

年龄 50 Years不限

Amgen

正在招募不适用NCT02617966

Rod and Cone Mediated Function in Retinal Disease

United States

年龄 5 Years100 Years

National Eye Institute (NEI)